chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I'm throwing up; have intense body chills; a severe headache.; I also dehydrate really quickly; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (I'm throwing up), CHILLS (have intense body chills), HEADACHE (a severe headache.) and DEHYDRATION (I also dehydrate really quickly) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (I'm throwing up), CHILLS (have intense body chills), HEADACHE (a severe headache.) and DEHYDRATION (I also dehydrate really quickly). At the time of the report, VOMITING (I'm throwing up), CHILLS (have intense body chills), HEADACHE (a severe headache.) and DEHYDRATION (I also dehydrate really quickly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.
Patient received moderna vaccine on 2/13/21 and 3/13/21. Presented to ER on 6/28/22 and found to be COVID positive. Admitted on 06/28/2022 on account of worsening mental status changes and generalized weakness. In the emergency room, he tested positive to COVID-19.  Chest x-ray and chest CT were negative for evidence of pneumonia. There is concern for possible meningitis. Patient has been started on broad-spectrum IV antibiotics.  Was also started on remdesivir and Decadron for possible COVID-19 pneumonia with hypoxia.  ABG showed pH 7.4, PO2 70, pCO2 30. Patient upgraded to ICU status due to obtundation. Pulmonology/critical care, and infectious disease consulted. IR consulted for LP; attempted 4 times but was a dry tap. Eventually accepted, Intensivist, and was transferred in stable condition on 6/30/22.  Patent's wife/POA, agreeable.
A report was received from a health care professional on 12/8/03 concerning five children of unspecified sex and aged between 8 months and 3 years of age who inadvertently received Fluvirin on 12/6/03. On 12/6/03, five children inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 3/8/04: Follow up information received from a health care professional indicated that a 1 year old female vaccinee inadvertently received Fluvirin on 12/6/03. No adverse reactions have been reported to date. No follow up pending, all information received.
Invalid Dose exceed 35 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Invalid Dose exceed 35 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Invalid Dose exceed 35 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Invalid Dose exceed 35 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were reported. No Treatment Medications were reported.   Reporter did not allow further contact
pt recvd vax & 15mins p/vax exp nausea & vomiting;
After receiving the covid vaccine the patient experienced lip tingling and tongue fullness. The patient does report having a high-risk allergy to oral amoxicillin and Percocet with hives. The patient was given oral Benedryl and the symptoms resolved.
Had the chills and fever at apox. midnight. It carried on until 8am 4-15-21.
Patient reports to the pharmacy 3 days after receiving the 2nd dose of his Pfizer vaccine, complaining of  complete numbness and loss of sensation in both hands along with swelling of right hand. Vaccine was received on the afternoon of 5/29 and patient reports a loss of sensation in both hands beginning that evening. This has continued for 3 days up to today morning (06/01) where patient reports some improvement in degree of swelling of right hand and a return of some feeling in both hands.
This case was reported by a other health professional via sales rep and described the occurrence of shingles in a adult patient who received SHINGRIX. On 7th May 2018, the patient received the 1st dose of SHINGRIX. On 8th May 2018, 1 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported.
Pt had a positive Streptococcus Pneumoniae on 11/9/01. Pt had received 2 prior doses of Prevnar on 7/11/00 and 9/9/001.
About an hour later I got a migraine and felt extremely fatigued. A few hours later my whole body is achy and severely nauseous. I had a fever I still feel horrible. Body aches, headache, nausea
Patient reported warmth, tenderness, redness, and slight swelling about 1 inch below injection site that went down a few inches above elbow on left arm.  No other issues reported. Pt was advised to monitor for progression of side effects.
At 6:00, hives appeared on my body, left covid arm broke out first in hives. Left hand became very swollen, and got worse through the night. The next day hand was still swollen.
Mother of patient reports hives at injection site and also at other areas of the body evening of immunization.
From initial information received on 7/12/04 from the patient's parent regarding an adverse event occurring in the USA, it was reported that a three year old male patient received his first TD ADS PED vaccination, lot number U0750AB, administered IM in the left thigh on 7/2/04 at 10:30 AM. The same day at 12:30 PM the patient became very lethargic and also developed a runny nose. The events reportedly lasted a few days and the patient recovered. He was not seen by a physician. From additional information received on 8/30/04 from a physician, it was reported that the patient was behind on his vaccinations at the time the product was administered. No other new medication information was provided. No further information is anticipated, this case is considered closed.
Headache, Myalgia, Arthralgia, fever, Diarrhea, injection site pain, swollen glands Narrative: Employee reports injection site pain/discomfort and itching, in addition to chills, fever (102 F), headache, fatigue, joint pain, body aches, diarrhea, fatigue, and swollen left axillary gland. Employee reports alternating Tylenol and Advil every 4-6 hours for symptoms. Employee not well enough to worked, stayed home.
Redness swelling and pain at site of injection and pain of whole arm.  Aching of whole body.
Pain in joints, pin and needles through-out body.  Post Flu shot Neuropathy.
Stool had black flecks in it. Did occult stool test and positive for blood.
one of our Bi-County Ambulance staff inadvertently used the same syringe to vaccinate eight people ? he did change the needles in between each patient.
Weakness; Body ache; diarrhoea; stomach  ache; Shivering; Fever; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), ARTHRALGIA (Body ache), DIARRHOEA (diarrhoea), ABDOMINAL PAIN UPPER (stomach  ache) and CHILLS (Shivering) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced ASTHENIA (Weakness), ARTHRALGIA (Body ache), DIARRHOEA (diarrhoea), ABDOMINAL PAIN UPPER (stomach  ache), CHILLS (Shivering), PYREXIA (Fever) and VOMITING (vomiting). At the time of the report, ASTHENIA (Weakness), ARTHRALGIA (Body ache), DIARRHOEA (diarrhoea), ABDOMINAL PAIN UPPER (stomach  ache), CHILLS (Shivering), PYREXIA (Fever) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Eczema-like patches appeared 2 weeks after my second dose of the Pfizer-BioNTech COVID19 vaccination. They were very red, extremely itchy, and appeared on my legs, arms, inner-elbow, and hands. They lasted for several weeks despite attempts at treatment which included over the counter eczema medication and various eczema and atopic dermatitis creams/lotions. These patches appear out of nowhere with no prior indications.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 30-OCT-2014, the patient was vaccinated with an expired 0.65 ml dose of ZOSTAVAX (lot # J000492 exp 19-JAN-2014) subcutaneously. No adverse experience was reported. Additional information has been requested.
3 weeks after receiving the flumist, started coughing and the throat hurt. Four days go by still continuing on coughing and throat hurts even more. Went to Physician was tested for strep, negative. Doctor then thought it could be from starting the heat in the house, (pellet stove)that the air was to dry so we set up humidifier. A week goes by coughing gets more continuious, night and day, head hurts, chest hurts. Go back to doctor andhe puts her on amoxicyllian and phenylhistine cough medicine. We finish the amoxicillian and the coughing is still going on but has become worse. Every time she coughs she can't seem to get enough air back into her lungs so she can breath. Went back to the doctors office and saw doctor. She put her on Biaxin and Advair. It's been four days and no sign of relief yet.
Patient inadvertently give 0.15 mL dose instead of required/recommended 0.3 mL dose. CDC contacted and advised to have patient return ASAP fto receive correct dosage. Patient returned 9/28/2021 and received 0.3 mL. No adverse affects reported per patient.
Patient, who is a minor under 6 years of age, accompanied by her mother, after being immunized with her first dose, while waiting for her 15 minutes in the observation room, she presented an itch in the Right arm, we proceed with the paramedic, who began taking vital signs and questions the mother. Vital signs were 100/60 for blood pressure and 99 breaths. The right arm presented erythema, so Doctor was called and she ordered that due to her age and weight, she would be administered 6 cc of BENADRYL and kept under observation for 30 minutes. It was discharged because everything was presented within the standards.
She experienced high blood sugar up to 300-400 which is far above her normal level of 180; She also had a sore arm which hurt, was red, swollen; Couldn't sleep at night; She also had a sore arm which hurt, was red/ looked red for over a week; Had a big red rash; She also had a sore arm which hurt/ arm hurt for 3 days; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Oct-2021 and was forwarded to Moderna on 22-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (She experienced high blood sugar up to 300-400 which is far above her normal level of 180), PERIPHERAL SWELLING (She also had a sore arm which hurt, was red, swollen), INSOMNIA (Couldn't sleep at night), PAIN IN EXTREMITY (She also had a sore arm which hurt/ arm hurt for 3 days) and ERYTHEMA (She also had a sore arm which hurt, was red/ looked red for over a week) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 088B, 001A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Wagner's disease (.). Concomitant products included PREDNISONE for Wagner's disease.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (She experienced high blood sugar up to 300-400 which is far above her normal level of 180), PERIPHERAL SWELLING (She also had a sore arm which hurt, was red, swollen), INSOMNIA (Couldn't sleep at night), PAIN IN EXTREMITY (She also had a sore arm which hurt/ arm hurt for 3 days), ERYTHEMA (She also had a sore arm which hurt, was red/ looked red for over a week) and RASH ERYTHEMATOUS (Had a big red rash). The patient was treated with GLIPIZIDE ongoing since an unknown date for Blood glucose, at a dose of 20 mg; TRAZODONE for Sleeplessness, at a dose of 1 dosage form and INSULIN for Blood sugar increased, at a dose of 1 dosage form. At the time of the report, BLOOD GLUCOSE INCREASED (She experienced high blood sugar up to 300-400 which is far above her normal level of 180), PERIPHERAL SWELLING (She also had a sore arm which hurt, was red, swollen), INSOMNIA (Couldn't sleep at night) and RASH ERYTHEMATOUS (Had a big red rash) outcome was unknown and PAIN IN EXTREMITY (She also had a sore arm which hurt/ arm hurt for 3 days) and ERYTHEMA (She also had a sore arm which hurt, was red/ looked red for over a week) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 300-400 (High) High blood sugar up to 300-400.
This is in follow-up to report(s) previously submitted on 11/14/2008. Information has been received from a health professional concerning a 16 week old female with no allergies or pertinent medical history who was vaccinated on 30-SEP-2008 with second dose of ROTATEQ. It was reported the child spit out an unknown amount of ROTATEQ while it was being administered. The child's first dose of ROTATEQ was administered at 2 months of age. Unspecified medical attention was given in the physician's office. No laboratory diagnostics were done. A product quality complaint was not involved. Additional information has been requested.
Patient was apprehensive prior to injection.  On way home from office, developed back pain, nausea, sweating.  While getting water, developed light headedness and tunnel vision, then experienced syncope.  Currently improved.
Mom states R leg swollen twice size down to knees. Took to ER for tx. Ice pack Benadryl x Tylenol given (no fever, no rash, skin/muscle normal to palpation, + movement in hip/thigh and knee without pain. Per ER report)
began w/listlessness & dizziness;t102.2 ax-advil given rt arm red & swollen;went to hosp about 1140PM;t100 ax states had an allergic rxn;prescribed pediaprofen & DPH;
Patient was seated in observation area after receiving first dose of Pfizer Covid vaccine. Due to patient reporting reaction to tetanus shot (after receiving Covid vaccine) patient was being observed for 30 minutes. Approximately 3-5 minutes into observation period, patient started to feel hot and flushed. Heart rate was approximately 65bpm on my assessment. Patient requested to lay down, in attempt to lay down, upon standing patient became weak, and unresponsive. Patient was assisted to ground carefully, without hitting head or falling to ground. Patient maintained airway, breathing and with a pulse throughout syncopal event. Patient was unresponsive for approximately 15-20 seconds, no seizure like activity, no loss of bowel or bladder. Patient aroused, was alert, oriented x3, making jokes, denied chest pain, shortness of breath, dizziness, headache, nausea, blurred vision, or any other symptoms. Upon discussion after syncopal event, patient informed staff that every singe time he has shots or blood draws he experiences syncope, and usually has to lay down for all procedures. EMS arrived and evaluated patient, patient left vaccine clinic on EMS stretcher. Patient advised to seek further medical attention, as well as inform his PCP and Cardiologist.
1/17/22 pt presented to hosp after multiple falls, weakness, worsening cognitive function, poor oral intake; previous ED visits for same sx on 1/17/22 and 1/24/22 at the local Medical Center; 1/17/22 found to be positive for COVID; COVID pneumonia; outside the window for remdesivir; given O2 supplementation; Decadron; experienced GI bleed; transferred to another unit; code blue was called for pt and she was intubated; another code blue occurred and the pt passed away in the hospital; DC and med records sent to info@vaers.org per VAERS request
8/19/21 transferred from an outside hospital for elevated troponins, retrosternal chest pain, and COVID-19 infection
Heavy/tight heart; This is a spontaneous report received from a contactable consumer or other non hcp. A 45-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP6955), Solution for injection, intramuscularly, administered in Arm Left on 12Apr2021 (at the age of 45-year-old) as single dose for covid-19 immunisation. Medical history reported as none. Patient was not allergic. The patient's concomitant medications were not reported. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and she did not receive any other medication within two weeks. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. Patient historic vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP6955), Solution for injection, intramuscular, administered in Arm Left on 23Mar2021 as single dose for covid-19 immunisation. On 12Apr2021, the patient experienced heavy/tight heart. Event was reported as non-serious by the reporter. Patient did not receive treatment due to adverse events. The outcome of events was reported as not recovered.  Follow-up actions are needed. Further information has been requested.  Follow-Up (07Jul2021): Follow-up attempts are completed. No further information is expected.
Tested positive after first dose of Moderna covid-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Tested positive after first dose of Moderna covid-19 vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive after first dose of Moderna covid-19 vaccine). At the time of the report, COVID-19 (Tested positive after first dose of Moderna covid-19 vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment drugs are not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: NNI
Accidentally given to patient <18 yo   PLEASE CONTACT DR with recommendations for 2nd shot administration
I was driving and my right side of my body started going numb. I couldn't lift my right foot to stop the car, so I had to use my left arm to put the car in park. So, I stopped the car and opened the car door and the numbness started leaving. I had no side affects so I went to the ER about 2 hours later had TIA.
respiratory failure with hysoxia secondary to COVID;  c/o SOB and diahrrea. treated with IV dexamethasone and abx
Fever up to 103 degrees before needing to take Tylenol to reduce symptoms and fever. Full body aches and chills x 6 hours. Throwing up x 4. L side flank pain. Fever from 8 pm to 6 am following day.
Patient was nervous about the vaccination and stated she had needle phobia.  She got her vaccine and felt great immediately after.  5-10 minutes after her vaccine she felt well and walked to the front of the pharmacy near our registers.  As we were talking she fainted and her mother tried to catch her.  She hit her head on the ground and a bump formed.  She stayed on the ground and her mother told us not to worry because this happens to her after any encounters with needles.   After 10-15 minutes after the fall, she sat up and felt better.  She declined further assessment and treatment and went home.
This case was reported by a other health professional via call center representative and described the occurrence of localized erythema in a 60-year-old female patient who received SHINGRIX (batch number 4492P, expiry date unknown) for prophylaxis. On 5th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced localized erythema, joint range of motion decreased, local swelling and discomfort. On an unknown date, the outcome of the localized erythema, joint range of motion decreased, local swelling and discomfort were recovered/resolved. The reporter considered the localized erythema, joint range of motion decreased, local swelling and discomfort to be possibly related to SHINGRIX. Additional details were provided as follows: This case was reported by the pharmacy student. The patient received SHINGRIX in the right deltoid. The healthcare professional did not have expiration date. In 2018, the patient experienced a localized reaction, which included redness, discomfort, decreased range of motion and swelling. The adverse events were resolved after 4 days.
Patient's mother left the school after patient received her injection. While in 15 min observation, patient c/o feeling dizzy & mild stomach discomfort. She was put in recumbent position on a floor mat. BP 88/66 skin warm & dry. No c/o dyspnea. School nurse transferred her via whchr to clinic to call her mother.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Severe, Additional Details: Patient became lightheaded due to fear of needles.  Was sitting in observation chair when he passed out & fell forward hitting his face on the floor.  His nose began to bleed profusely but after a few seconds he regained consciousness and sat up on his own.  Emergency services were called to make sure he was ok (ie. no broken nose).  Patient was assessed by EMT and found to be okay (blood pressure, blood glucose, pulse)We observed him for a full hour before allowed to leave.